111 related articles for article (PubMed ID: 1582134)
1. Splanchnic and renal vasoconstriction during neuropeptide Y infusion in healthy humans.
Ahlborg G; Weitzberg E; Lundberg JM
Clin Physiol; 1992 Mar; 12(2):145-53. PubMed ID: 1582134
[TBL] [Abstract][Full Text] [Related]
2. Splanchnic and renal vasoconstrictor and metabolic responses to neuropeptide Y in resting and exercising man.
Ahlborg G; Weitzberg E; Sollevi A; Lundberg JM
Acta Physiol Scand; 1992 Jun; 145(2):139-49. PubMed ID: 1636443
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of neuropeptide Y on splanchnic glycogenolysis and renin release in humans.
Ahlborg G; Lundberg JM
Clin Physiol; 1994 Mar; 14(2):187-96. PubMed ID: 8205750
[TBL] [Abstract][Full Text] [Related]
4. Vasoconstrictor effects in vivo and plasma disappearance rate of neuropeptide Y in man.
Pernow J; Lundberg JM; Kaijser L
Life Sci; 1987 Jan; 40(1):47-54. PubMed ID: 3796213
[TBL] [Abstract][Full Text] [Related]
5. Splanchnic release of neuropeptide Y during prolonged exercise with and without beta-adrenoceptor blockade in healthy man.
Ahlborg G; Lundberg JM
Clin Physiol; 1991 Jul; 11(4):343-51. PubMed ID: 1680600
[TBL] [Abstract][Full Text] [Related]
6. Release and vasoconstrictor effects of neuropeptide Y in relation to non-adrenergic sympathetic control of renal blood flow in the pig.
Pernow J; Lundberg JM
Acta Physiol Scand; 1989 Aug; 136(4):507-17. PubMed ID: 2571235
[TBL] [Abstract][Full Text] [Related]
7. Big ET-1 infusion in man causes renal ET-1 release, renal and splanchnic vasoconstriction, and increased mean arterial blood pressure.
Ahlborg G; Ottosson-Seeberger A; Hemsén A; Lundberg JM
Cardiovasc Res; 1994 Oct; 28(10):1559-63. PubMed ID: 8001046
[TBL] [Abstract][Full Text] [Related]
8. Effect of oral administration of nifedipine on neuropeptide Y- and noradrenaline-induced vasoconstriction in the human forearm.
Pernow J; Lundberg JM; Kaijser L
Clin Physiol; 1989 Feb; 9(1):67-75. PubMed ID: 2706916
[TBL] [Abstract][Full Text] [Related]
9. C-peptide potentiates the vasoconstrictor effect of neuropeptide Y in insulin-dependent diabetic patients.
Johansson BL; Pernow J
Acta Physiol Scand; 1999 Jan; 165(1):39-44. PubMed ID: 10072095
[TBL] [Abstract][Full Text] [Related]
10. Long-lasting vasoconstriction and efficient regional extraction of endothelin-1 in human splanchnic and renal tissues.
Weitzberg E; Ahlborg G; Lundberg JM
Biochem Biophys Res Commun; 1991 Nov; 180(3):1298-303. PubMed ID: 1953780
[TBL] [Abstract][Full Text] [Related]
11. Renal actions of neuropeptide Y in the primate.
Echtenkamp SF; Dandridge PF
Am J Physiol; 1989 Apr; 256(4 Pt 2):F524-31. PubMed ID: 2705532
[TBL] [Abstract][Full Text] [Related]
12. Effects of the neuropeptide Y Y2 receptor antagonist BIIE0246 on sympathetic transmitter release in the pig in vivo.
Malmström RE; Lundberg JN; Weitzberg E
Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):106-11. PubMed ID: 11819028
[TBL] [Abstract][Full Text] [Related]
13. Interaction of neuropeptide Y and the sympathetic nervous system in vascular control in man.
Clarke J; Benjamin N; Larkin S; Webb D; Maseri A; Davies G
Circulation; 1991 Mar; 83(3):774-7. PubMed ID: 1999028
[TBL] [Abstract][Full Text] [Related]
14. Elevations of neuropeptide Y-like immunoreactivity and catecholamines in plasma on increased intracranial pressure in the pig.
Rudehill A; Lundberg JM; Sollevi A; Hjemdahl P
Acta Anaesthesiol Scand; 1987 Feb; 31(2):132-8. PubMed ID: 3564869
[TBL] [Abstract][Full Text] [Related]
15. The effects of age on human venous responsiveness to neuropeptide Y.
Lambert ML; Callow ID; Feng QP; Arnold JM
Br J Clin Pharmacol; 1999 Jan; 47(1):83-9. PubMed ID: 10073744
[TBL] [Abstract][Full Text] [Related]
16. Circulating endothelin-1 reduces splanchnic and renal blood flow and splanchnic glucose production in humans.
Ahlborg G; Weitzberg E; Lundberg JM
J Appl Physiol (1985); 1995 Jul; 79(1):141-5. PubMed ID: 7559211
[TBL] [Abstract][Full Text] [Related]
17. In vivo characterization of the novel neuropeptide Y Y1 receptor antagonist H 409/22.
Malmström RE; Alexandersson A; Balmér KC; Weilitz J
J Cardiovasc Pharmacol; 2000 Oct; 36(4):516-25. PubMed ID: 11026655
[TBL] [Abstract][Full Text] [Related]
18. Possible involvement of neuropeptide Y in sympathetic vascular control of canine skeletal muscle.
Pernow J; Kahan T; Hjemdahl P; Lundberg JM
Acta Physiol Scand; 1988 Jan; 132(1):43-50. PubMed ID: 2906210
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of neuropeptide Y and noradrenaline on rat gastric mucosal blood flow and integrity.
Tepperman BL; Whittle BJ
Br J Pharmacol; 1991 Jan; 102(1):95-100. PubMed ID: 2043936
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms involved in colonic vasoconstriction and inhibition of motility induced by neuropeptide Y.
Hellström PM
Acta Physiol Scand; 1987 Apr; 129(4):549-56. PubMed ID: 3591377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
